Back to results
US 2010/0063059 A1Published application
Novel pyridazine compound and use thereof
AssigneesGerhard Puerstinger, Gilead Sciences, Inc., K. U. Leuven Research & Development
InventorsSteven S. Bondy, Terrence C. Dahl, David A. Oare, Reza Oliyai, Winston C. Tse, Vahid Zia
Life of this patent
Estimating the term…
Abstract
A compound of formula (1) and its salts and solvates are provided for the treatment or prophylaxis of hepatitis C virus infections. Methods of making and formulating compound (1) are provided.
Claims27
A method for making a compound of formula (1)
- comprising (a) reacting 5-[6-chloro-pyridazin-3-ylmethyl]-2-(2-fluoro-phenyl)-5H-imidazo[4,5-c]pyridine with 2,4-bis(trifluromethyl)phenylboronic acid in the presence of a solvent having the structure R1OR2O(R4O)aR3 wherein each of R1, R2, R3 and R4 are independently selected from C1-C6 alkyl and a is 0 or 1, and (b) recovering compound (1).
A compound having the formula (1)
- and the salts and solvates thereof.
A method for the preparation of compound (1) comprising providing the intermediate (2)
- coupling 2,4-bis(trifluoromethyl)phenylboronic acid to 3-chloro-6-methylpyridazine to produce compound (2a)
- treating compound (2a) with a chlorinating agent to produce the alkylating agent (3)
- and using alkylating agent (3) to alkylate intermediate (2)under basic conditions to yield compound (1)
A compound of formula (3)
- and its analogues substituted with methyl rather than chloromethyl, and its analogues substituted with bromo, fluro or iodo in place of chloro.
Dependencies are inferred from the claim text.